MedWellAI Increases Authorized Series B Convertible Preferred Stock by 50%

summarizeSummary

MedWellAI, Inc. increased its authorized Series B Convertible Preferred Stock by 50% to 1.5 million shares, a move likely aimed at enabling future capital raises amidst financial distress.

check_boxKey Events

• Increased Authorized Preferred Stock

  MedWellAI, Inc. amended its Certificate of Designation to increase the authorized Series B Convertible Preferred Stock from 1,000,000 to 1,500,000 shares.

• Shareholder Approval

  The amendment was approved by holders of 90% of the outstanding Series B Preferred Stock on April 13, 2026.

• Enables Future Financing

  This authorization provides the company with additional capacity to issue preferred shares, likely in preparation for future capital raises to address its financial challenges, including a previously reported going concern warning.

auto_awesomeAnalysis

MedWellAI, Inc. has increased its authorized Series B Convertible Preferred Stock by 50%, from 1,000,000 to 1,500,000 shares. This action, approved by a supermajority of existing preferred shareholders, is a preparatory step for potential future capital raises. Given the company's previously disclosed significant working capital deficit and going concern warning, this authorization provides necessary flexibility to secure financing, but also signals potential significant dilution for common shareholders if these preferred shares are issued and subsequently converted.